Alacritech Inc. v. CenturyLink, Inc.

Filing 909

MEMORANDUM ORDER. Signed by Magistrate Judge Roy S. Payne on 10/12/2023. (nkl, )

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF TEXAS
MARSHALL DIVISION
ALACRITECH INC.,
Plaintiff,
v.
CENTURYLINK, INC. et al,
Defendants.

§
§
§
§
§
§
§
§
§

CIVIL ACTION NO. 2:16-CV-00693-RWS-RSP
(LEAD CASE)

MEMORANDUM ORDER
Alacritech recently filed a motion to supplement Mr. Gunderson’s damages report (Dkt.
No. 833), which the Court GRANTED at the September 28, 2023 Pretrial Conference. Before the
Court is Intel Corporation and Dell Inc.’s (“Defendants”) Daubert Motion to Exclude Testimony
of Plaintiff Alacritech, Inc.’s Damages Expert Lance Gunderson (Dkt. No. 860) based on that
recent supplemental report. For the following reasons, the motion is DENIED.
I.

BACKGROUND
On June 30, 2016, Plaintiff Alacritech Inc. filed suit against CenturyLink, Inc., Tier 3, Inc.,

Savvis Communications Corp., CenturyLink Communications LLC, Cyxtera Communications,
LLC, Winston Corporation, Wiwynn Corporation, SMS InfoComm Corporation, and Dell Inc.
alleging certain server products and methods infringe eight of Alacritech’s patents. 1 Intel
Corporation intervened in this case on November 21, 2016, and Cavium, Inc. intervened on
February 14, 2017, both asserting that their products were implicated in the infringement
allegations. Dkt. No. 84 (Intel); Dkt. No. 127 (Cavium).

Winston Corporation, Wiwynn Corporation, and SMS InfoComm Corporation were consolidated for pretrial from
Case No. 2:16-CV-692-RWS-RSP, and Defendant Dell Inc. was consolidated for pretrial from Case No. 2:16-CV695-RWS-RSP.
1

1

This case proceeded through discovery and was stayed pending disposition of inter partes
review (IPR) proceedings that had been instituted by the Patent Trial and Appeal Board. Dkt.
No. 451. The PTAB invalidated multiple claims challenged in IPRs, Alacritech appealed that
decision, and the Court continued the stay pending resolution of the Federal Circuit appeal. Dkt.
No. 482. In 2022, following the appeal proceedings, Alacritech moved to lift the stay and proceed
with its case on the surviving patents and claims.
The Court lifted the stay and entered Docket Control Orders for the respective cases. See
Dkt. No. 786 (setting February 20, 2024 trial date for certain defendants in the 2:16-CV-693 and
2:16-CV-692 cases); 2:16-CV-00695-RWS-RSP, Dkt. No. 19 (setting October 16, 2023 trial date
for Dell). Now, Alacritech asserts claim 1 of U.S. Patent No. 7,124,205 (the “’205 Patent”), claims
17 and 22 of U.S. Patent No. 8,805,948 (the “’948 Patent”), and claim 41 of U.S. Patent No.
8,131,880 (the “’880 Patent”) (collectively, “Asserted Patents”) against Defendant Dell Inc. and
Intervenor Intel Corporation of the ’695 Member Case, and defendants Winstron Corporation,
Wiwynn Corporation, SMS InfoComm Corporation of the ’692 Member Case. 2 See Dkt. No. 522
at 1.
II.

LAW
In a suit for patent infringement, a successful plaintiff is entitled to “damages adequate to

compensate for the infringement, but in no event less than a reasonable royalty for the use made
of the invention by the infringer, together with interest and costs as fixed by the court.” 35
U.S.C. § 284. An assessment of the reasonable royalty generally involves opinions by expert
witnesses.

2

The other defendants and intervenor Cavium are no longer in the case or will soon be dismissed.

2

An expert witness may provide opinion testimony if “(a) the expert's scientific, technical,
or other specialized knowledge will help the trier of fact to understand the evidence or to determine
a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product
of reliable principles and methods; and (d) the expert has reliably applied the principles and
methods to the facts of the case.” FED. R. EVID. 702.
Rule 702 requires that judges act as gatekeepers to ensure “that an expert’s testimony both
rests on a reliable foundation and is relevant to the task at hand.” Daubert v. Merrell Dow
Pharmaceuticals, Inc., 509 U.S. 579 (1993). However, “[t]he inquiry envisioned by Rule 702 is ...
a flexible one.” Id. at 594; see also Kumho Tire Co. v. Carmichael, 526 U.S. 137, 150
(1999) (“Daubert makes clear that the factors it mentions do not constitute a ‘definitive checklist
or test.’”). While the party offering the expert bears the burden of showing that the testimony is
reliable, it “need not prove to the judge that the expert’s testimony is correct....” Johnson v.
Arkema, Inc., 685 F.3d 452, 459 (5th Cir. 1999) (citing Moore v. Ashland Chem. Inc., 151 F.3d
269, 276 (5th Cir. 1998)). Ultimately, “the question of whether the expert is credible or the opinion
is correct is generally a question for the fact finder, not the court.” Summit 6, LLC v. Samsung
Elecs. Co., 802 F.3d 1283, 1296 (Fed. Cir. 2015) (citation omitted). “Vigorous cross-examination,
presentation of contrary evidence, and careful instruction on the burden of proof are the traditional
and appropriate means of attacking shaky but admissible evidence.” Daubert, 509 U.S. at
596 (citation omitted).
III.

ANALYSIS
Alacritech retained Lance Gunderson as its damages expert. After the stay was lifted, Mr.

Gunderson served a supplemental damages report on June 23, 2023. Since then, Alacritech has
entered into settlement and license agreements with defendant Cavium, non-party NVIDIA
(collectively, “Recent Agreements”), and former defendant CenturyLink. The Recent Agreements
3

include (1) a covenant not to sue for the Asserted Patents, (2) a settlement of litigation, (3) a
covenant not to sue for additional non-asserted patents, and (4) a release covering additional nonasserted patents. To account for how these events affect a reasonable royalty, Mr. Gunderson has
another supplemental report, dated September 20, 2023. See Dkt. No. 833-2 (Mr. Gunderson
9/20/23 Supplemental Report).
In his September 20, 2023 Supplemental Report, Mr. Gunderson opines that the Recent
Agreements are both technologically and economically comparable to the hypothetical negotiation
because they grant the right to use the specific patented technology at issue in the products accused
in this case. Id. at ¶¶ 21, 24, 26. He also opines that the primary driver of value is the Asserted
Patents and right to use the Asserted Patents based on the timing of those settlement agreements
relative to the imminent trial date. Id. at ¶¶ 4, 24.
Mr. Gunderson explains that the Cavium agreement supports the

royalty rate estimate

from his earlier report. Id. at ¶¶ 12, 19.
He also opines that the NVIDIA agreement supports a larger implied royalty applicable to
Intel, which falls within the range of his previous reasonable royalty calculation. Id. at ¶ 20. To
arrive at that conclusion, he applies a market share adjustment based on Intel and NVIDIA’s
accused sales relative to the settlement payment.
Defendants seek to exclude Mr. Gunderson’s damages opinions as allegedly failing to
satisfy the reliability requirements of Rule 702 and Daubert. Motion, Dkt. No.860 at 1. Defendants
argue that Mr. Gunderson’s damages opinions are unreliable because (1) he calculates damages
from the Recent Agreements without accounting for how any covered non-asserted patents affect
the payments in those agreements, (2) he fails to apportion the non-accused features, and (3) he

4

fails to demonstrate that the Recent Agreements are economically and technically comparable as
required by Federal Circuit law. Id. at 1–2.
A. Mr. Gunderson Adequately Addresses the Other Patents in the Recent
Agreements
First, Defendants argue that Mr. Gunderson violates apportionment law by failing to
account for the non-asserted patents covered by the Recent Agreements. Motion, Dkt. No. 860 at
9 (citing Apple Inc. v. Wi-LAN Inc., 25 F.4th 960, 973 (Fed. Cir. 2022) (holding expert’s opinions
were unreliable where he failed to address the extent to which five of the six patents contributed
to the royalty rate in a comparable license, while still opining that excluding those five patents
would have only resulted in a 25% discount); VirnetX, Inc. v. Cisco Systems, Inc., 767 F.3d 1308,
1328–29 (Fed. Cir. 2014) (holding expert’s opinion should have been excluded for failure to
apportion value of non-patented technology); LaserDynamics, Inc. v. Quanta Computer, Inc., 694
F.3d 51, 69 (Fed. Cir. 2012) (holding expert’s opinions were unreliable because he arbitrarily
reduced the royalty rate by 2/3 “based on vague qualitative notions of the relative importance” of
the technology at issue)). According to Defendants, Mr. Gunderson attributed the full amount of
the Recent Agreements solely to the Asserted Patents without attributing any value to the rights
regarding the non-asserted patents thereby running afoul of apportionment law. Id. at 10.
In response, Alacritech represents that Mr. Gunderson (1) does not use new methodologies
in his supplemental report, and (2) uses the Recent Agreements to confirm the reasonableness of
the royalties he previously calculated in his principal report that were already apportioned.
Response, Dkt. No. 867 at 5–6.
The Federal Circuit has held “that when a sufficiently comparable license is used as the
basis for determining the appropriate royalty, further apportionment may not necessarily be
required.” Vectura Ltd. v. Glaxosmithkline LLC, 981 F.3d 1030, 1040 (Fed. Cir. 2020) (collecting
5

cases). “That is because a damages theory that is dependent on a comparable license (or a
comparable negotiation) may in some cases have ‘built-in apportionment,’” which “effectively
assumes that the negotiators of a comparable license settled on a royalty rate and royalty base
combination embodying the value of the asserted patent.” Id. at 1040–41. “Use of actual past
licenses and negotiations to inform the hypothetical negotiation does not ‘require[ ] identity of
circumstances.’” Elbit Sys. Land & C4I Ltd. v. Hughes Network Sys., LLC, 927 F.3d 1292, 1301
(Fed. Cir. 2019) (quoting Virnetx, Inc v. Cisco Sys., Inc., 767 F.3d 1308, 1330 (Fed. Cir. 2014)).
The Court is not persuaded that Mr. Gunderson’s analysis is inconsistent with Federal
Circuit authority because he addresses the non-asserted patents. In his September 20, 2023
Supplemental Report, Mr. Gunderson opines that “[t]he primary driver of the value of the
Alacritech-Cavium Settlement Agreement appears to be the right to use the inventions in the
patents at issue claimed by Alacritech in this litigation given that the agreement settled the lawsuit
asserting the three patents at issue on the eve of trial.” Dkt. No. 833-2 (Mr. Gunderson 9/20/23
Supplemental Report) at ¶ 24. He goes on to explain, in his opinion, why the Asserted Patents
account for effectively all of the material value for the Cavium agreement, including that other
patents are now expired, there are no additional asserted claims against Cavium, and the release
itself. Id. He also offers similar opinions and explanations for the NVIDIA agreement. Id. at ¶ 26.
Further, Apple is distinguishable because, here, Mr. Gunderson addresses the extent to
which the non-asserted patents contribute to the royalty rate, and he opines they contribute nothing.
25 F.4th at 973.
Consequently, Mr. Gunderson’s damages opinions adequately address the other patents
included in the Patent Licenses in accordance with apportionment law, and his methodology is
sufficiently tied to the facts of the case. Summit 6, 802 F.3d at 1296 (“But where the methodology

6

is reasonable and its data or evidence are sufficiently tied to the facts of the case, the gatekeeping
role of the court is satisfied, and the inquiry on the correctness of the methodology and of the
results produced thereunder belongs to the factfinder.”). The inquiry into the correctness of Mr.
Gunderson’s analysis regarding the non-asserted patents can be properly explored through
vigorous cross-examination and presentation of contrary evidence. Daubert, 509 U.S. at 596.
B. Mr. Gunderson’s Use of Intel’s Sales and Revenues in the Recent Agreements
is Not Improper
Second, Defendants argue that (1) Mr. Gunderson calculates an effective royalty rate and
per-unit royalty rate for Cavium without proper apportionment, and (2) Mr. Gunderson fails to
apportion because he determines a product sale multiplier by comparing all of Intel’s accused sales
to NVIDIA’s unit sales to three of NVIDIA’s customers. Motion, Dkt. No. 860 at 10–11.
Alacritech responds that Mr. Gunderson relies on built-in apportionment based on his
analysis that the Recent Agreements reflect a built-in apportionment. Response, Dkt. No. 867 at
9–10.
The Court is not persuaded that Mr. Gunderson’s analysis is inconsistent with Federal
Circuit authority. In his September 20, 2023 Supplemental Report, Mr. Gunderson opines that the
Recent Agreements are both technologically and economically comparable to the hypothetical
negotiation because they grant the right to use the specific patented technology at issue in the
products accused in this case. Dkt. No. 833-2 (Mr. Gunderson 9/20/23 Supplemental Report) at
¶¶ 21, 24, 26. For technological comparability, Mr. Gunderson opines that the technology at issue
in the Recent Agreements involve “the same types of NICs alleged to incorporate the same
patented RSC technology at issue in this case,” covered by the asserted claims. Id. at ¶¶ 24, 26.
For economic comparability, Mr. Gunderson opines that both Cavium and NVIDIA operate as
product sellers with respect to the accused products and Defendants also operate as product sellers
7

with respect to the accused products. Mr. Gunderson also explains that the payments under the
Recent Agreements compensate only for the value of similar products to the claimed RSC at issue
in this case.
Consequently, Mr. Gunderson has provided an adequate basis to rely on the built-in
apportionment of the Recent Agreements. Vectura, 981 F.3d at 1040–41. His opinions are also
sufficiently tied to the facts of the case to clear the reliability hurdle. Summit 6, 802 F.3d at 1296.
The inquiry into the correctness of Mr. Gunderson’s analysis can be properly explored through
vigorous cross-examination and presentation of contrary evidence. Daubert, 509 U.S. at 596.
C. Mr. Gunderson Adequately Explains the Comparability of the Recent
Agreements
Finally, Defendants argue that Mr. Gunderson fails to show that the Recent Agreements
are sufficiently comparable to a hypothetical license to the Asserted Patents to justify reliance on
them. Motion, Dkt. No. 860 at 13–15. Alacritech responds that Mr. Gunderson explains the
economic and technical comparability of the Recent Agreements. Response, Dkt. No. 867 at 10–
14.
Here, as previously discussed in Section II(B), Mr. Gunderson explains why, in his opinion,
the Recent Licenses are both economically and technically comparable to the RSC technology at
issue in this case. Further, the Court has already analyzed Mr. Gunderson’s original report and
determined that he provides an adequate basis to rely on a built-in apportionment for the previous
license agreements. Mr. Gunderson’s original report also includes a full Georgia-Pacific analysis,
and he discusses the consistent value and technical benefits of RSC from 2009 through the present
when he addresses factors 9 and 10. Dkt. No. 867-3 (Mr. Gunderson’s 6/23/23 Supplemental
Report) at ¶¶ 409–96, 503.

8

Defendants cite cases as to the age of license agreements in a changing technological and
financial landscape. Odetics Inc. v. Storage Tech. Corp., 185 F.3d 1259, 1276–77; LaserDynamics,
694 F.3d at 80
But those cases do not establish a per se rule against relying on agreements well after the
hypothetical negotiation date. Compare Odetics, 185 F.3d 1259, 1276–77 (holding the district
court did not abuse its discretion by excluding licenses entered into four and five years after the
date of first infringement due to “the age of the license agreements, in the context of the changing
technology and ‘financial landscape’ at issue) with LaserDynamics, 694 F.3d at 78 (holding district
court abused its direction by admitting the BenQ settlement agreement into evidence because the
BenQ license was executecd shortly before a trial in which BenQ would have been subject to
numerous harsh sanctions imposed on it by the district court, and it further involved a lump sum
six times higher than the next highest amount paid for a license to the patents-in-suit).
Here, neither Cavium nor NVIDIA were subject to harsh sanctions and nothing establishes
their license agreements were significantly above the terms of any others. Mr. Gunderson explains
the effect of the passage of time on RSC technology and cites evidence directly from Defendants
to establish that comparability.
Consequently, Mr. Gunderson has provided adequate support for the economic and
technical comparability of the Recent Agreements to avoid their exclusion. In his June 2023 report,
he offers opinions accounting for the differences in date from execution to the date of first
infringement, and the changing and technological landscape. His opinions are also sufficiently tied
to the facts of the case to clear the reliability hurdle. Summit 6, 802 F.3d at 1296. The inquiry into
the correctness of Mr. Gunderson’s analysis can be properly explored through vigorous crossexamination and presentation of contrary evidence. Daubert, 509 U.S. at 596.

9

IV.

CONCLUSION
For the reasons above, Defendants’ Daubert Motion to Exclude Testimony of Alacritech’s

Damages Expert Lance Gunderson (Dkt. No. 860) is hereby DENIED.
y
y
SIGNED this 12th day of October, 2023.

____________________________________
ROY S. PAYNE
UNITED STATES MAGISTRATE JUDGE

10